Overview
- 11 inspections across 11 sites are on record.
- 23 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2023-01-27.
At a glance
Inspections
11
Sites
11
Observations
23
Career since
Oct 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Modavar Pharmaceuticals | 27 Jan 2023 | Human Drugs | View 483 → |
| Celltrion Branchburg, LLC | 25 Aug 2022 | Human Drugs | On file |
| Cape Drugs | 2 Dec 2021 | Human Drugs | View 483 → |
| Pharmaceutics International, Inc. | 29 Sep 2021 | Human Drugs | On file |
| Pharmaceutics International, Inc. | 29 Sep 2021 | Human Drugs | On file |
Sites inspected
Modavar PharmaceuticalsFrederick, United States1 insp.
Celltrion Branchburg, LLCBranchburg, United States1 insp.
Cape DrugsAnnapolis, United States1 insp.
Pharmaceutics International, Inc.Hunt Valley, United States1 insp.
Pharmaceutics International, Inc.Cockeysville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Lauren N Barber3 shared
Shirshendu K Deb2 shared
Viviana Matta2 shared
Marcellinus D Dordunoo2 shared
Edward P Potter2 shared
Amy N Chen1 shared
Jazmine N Brown1 shared
Edmund F Mrak1 shared
Derek S Smith1 shared
Sena G Dissmeyer1 shared
Full investigator report
Get the verbatim findings behind Kathleen M Jordan's 23 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site